Mereo BioPharma (MREO) Other financing activities (2024 - 2025)
Mereo BioPharma (MREO) reported Other financing activities of $134000.0 for Q2 2025, down 86.6% year-over-year from $1000000.0 in Q2 2024, and up 106.15% quarter-over-quarter from $65000.0 in Q1 2025.
Mereo BioPharma (MREO) Other financing activities (2024 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has 2 years of Other financing activities data on file, last reported at $134000.0 in Q2 2025.
- Other financing activities for Q2 2025 came in at $134000.0, down 86.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $134000.0 (down 92.11% YoY), and the FY2025 annual result was $199000.0, down 76.67% from the prior year.
- Other financing activities rose to $134000.0 in Q2 2025 per MREO's latest filing, from $65000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $1.0 million in Q2 2024 and troughed at $40000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 594,000.00 |
| Sep 30, 2024 | 594,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |